Helimeds

How much weight can you lose on Wegovy?

Weight Loss4 min read
Dr. Alexandra Christiansen, MD

Medically reviewed by: Dr. Alexandra Christiansen, MD

Written by: Dr. Sadi Erfani MD

Fact Checked

Helimeds’ Fact-Checking Standards. Every piece of content at Helimeds adheres to the highest editorial standards for language, style, and medical accuracy. To learn what we do to deliver the best health insights to you, check out our content review principles.

In a clinical trial, adults taking the 2.4 mg weekly Wegovy® injection lost an average of about 15% of their starting body weight over 68 weeks, alongside a reduced-calorie diet and increased physical activity. For someone starting at 200 pounds, 15% is 30 pounds. (pubmed.ncbi.nlm.nih.gov)

That figure is a study average, not a prediction or a limit on what you can lose. Some participants lost more and others lost less. The trial included adults with obesity or overweight and a weight-related condition who did not have diabetes. The reported results apply to the injection studied, not to every form or dose of semaglutide.

What does 15% weight loss look like?

The number of pounds represented by a percentage depends on your starting weight:

Starting weight15% of starting weight
180 pounds27 pounds
200 pounds30 pounds
250 pounds37.5 pounds

These examples show the math, not expected individual results. To calculate a percentage of your own starting weight, multiply it by 0.15. A licensed provider can help you set goals that take your health and circumstances into account.

What about Wegovy HD?

A separate study looked at a higher-dose injection, Wegovy HD, over 72 weeks. Participants lost an average of approximately 19% of their starting weight. As with the other trial, participants also received diet and physical activity guidance. Results varied among individuals. (pubmed.ncbi.nlm.nih.gov)

A higher dose is not necessarily appropriate for everyone. Your provider considers your response, side effects and medical history when deciding on treatment. Do not change your dose to try to reach a study average.

How long does weight loss take?

Weight loss with Wegovy generally develops over months rather than all at once. The injection is started at a lower dose and increased gradually to help the body adjust. Some people notice changes in appetite early, but the timing and amount of weight change differ.

The 15% figure above was measured after 68 weeks. It should not be interpreted as a monthly rate or a promise that you will lose a set number of pounds by a particular date. Weight loss can also slow or level off over time.

If your progress looks different from a trial average, discuss it with your provider rather than adjusting treatment on your own. They can review your progress alongside tolerability, other medications and your overall health.

What can affect your results?

Wegovy contains semaglutide, a medication that acts on GLP-1 receptors involved in appetite regulation. It can help reduce hunger and increase feelings of fullness, but the response is individual.

Several factors may affect your experience:

  • Your treatment plan and tolerability. Side effects can influence whether a provider recommends continuing treatment or changing the plan.
  • Other health conditions and medications. These are part of the provider’s assessment and may affect weight management.
  • Eating and activity habits. The trial results were measured alongside a reduced-calorie diet and increased physical activity.
  • Time on treatment. An early weight change does not necessarily predict your longer-term result.

A practical plan can include meals with a mix of protein, fruits or vegetables, and whole grains, as well as physical activity suited to your abilities. Strength-based activity can be part of a plan to maintain muscle during weight loss. If reduced appetite or side effects make it hard to eat or drink enough, tell your provider.

Safety and treatment suitability

Wegovy can cause side effects, including nausea, vomiting, diarrhea, constipation and stomach pain. More serious problems can include pancreatitis, gallbladder problems, kidney problems and serious allergic reactions. Contact your provider about severe or persistent symptoms. Seek urgent medical help for signs of a serious allergic reaction, such as trouble breathing or swelling of the face or throat. (accessdata.fda.gov)

Wegovy is not appropriate for people with a personal or family history of medullary thyroid carcinoma, a type of thyroid cancer, or for people with multiple endocrine neoplasia syndrome type 2. Before treatment, discuss your full medical history, medications and any pregnancy or pregnancy plans with your provider. The Wegovy safety overview describes these and other considerations. (weightwatchers.com)

Wegovy is an FDA-approved branded medication. Compounded semaglutide is not FDA-approved, and it should not be described as equivalent to or interchangeable with Wegovy. The Wegovy trial averages in this article do not establish how a compounded preparation will perform. (helimeds.com)

If you want to discuss a Wegovy treatment pathway through Helimeds, complete a medical intake and consult with a licensed provider. Treatment may be prescribed only if clinically appropriate and permitted in your state, with fulfillment through a licensed pharmacy partner.

What happens if you stop?

Weight management may require a long-term plan. Some weight can return after stopping semaglutide, although the amount varies. A provider can help you consider the benefits and risks of continuing treatment and make a plan if you need to stop. Do not discontinue or change a prescription solely because you have reached a particular number on the scale. (pubmed.ncbi.nlm.nih.gov)

The most useful starting point is a conversation about your health, realistic goals and treatment options. You can begin the intake process with Helimeds to discuss whether Wegovy or another approach may be appropriate after provider review.

History

  1. Current Version

    Written by Dr. Sadi Erfani MD

    Medically reviewed by Dr. Alexandra Christiansen, MD